Literature DB >> 187053

Metabolism of vitamin D: current status.

H F DeLuca.   

Abstract

There has been much progress in our understanding of the metabolism of vitamin D. It is now clear that vitamin D3 can be produced in the skin or ingested in the diet. It accumulates very rapidly in the liver where it undergoes 25-hydroxylation, yielding 25-OH-D3, the major circulating metabolite of the vitamin. 25-OH-D3 proceeds to the kidney where it undergoes one of two hydroxylations. If there is a biological need for calcium or for phosphate the kidney is stimulated to convert 25-OH-D3 to the 1,25-(OH)2-D3, a calcium and phosphate mobilizing hormone. If, however, the animal has sufficient supplies of calcium and phosphate, the l-hydroxylase is shut down and instead the 25-OH-D3 is converted to a 24,25-(OH)2D3. The role of the 24,25-(OH)2D3 remains unknown; it may be an intermediate in the inactivation-excretion mechanism. 1,25-(OH)2D3 proceeds to the intestine where it stimulates intestinal calcium transport and intestinal phosphate transport. It also stimulates bone calcium mobilization and probably has other effects yet to be discovered in such tissues as muscle. The 25-OH-D3-l-hydroxylase, which is located exclusively in renal mitochondria, has been shown to be a three component system involving a flavoprotein, an iron-sulfur protein (renal ferredoxin), and a cytochrome P-450. This system has been successfully solubilized, the components isolated, and reconstituted. The 24-hydroxylase, however, has not yet been thoroughly studied. 1,25-(OH)2D3 is necessary for the appearance of the 24-hydroxylase; parathyroid hormone represses 24-hydroxylation. It is possible that the 24-hydroxylase represents the major regulated enzyme, so that its presence or absence may determine whether 1,25-(OH)2D3 is produced. Two metabolic pathways for 1,25-(OH)2D3 are known, conversion by the 24-hydroxylase to 1,24,25-(OH)3D3, and conversion of 1,25-(OH)2D3 to an unknown substance. In the latter instance, there occurs loss of a side chain piece, including at least one of the 26 and 27 carbons. Whether 1,25-(OH)2D3 must be metabolized further before it carries out all of its functions has yet to be established. The primary excretion route of vitamin D3 is via the bile into the feces. Urinary excretion appears small in magnitude and no excretion products have yet been identified positively. Much remains to be learned concerning the metabolism and function of vitamin D and its metabolites. This should therefore, prove to be a fruitful area of investigation for many years to come, especially since 1,25-(OH)2D3, 25-OH-D3, and lalpha-OH-D3 have been shown to be effective in a number of metabolic bone disease states.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187053     DOI: 10.1093/ajcn/29.11.1258

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  17 in total

Review 1.  Drugs and vitamin deficiency.

Authors:  L Ovesen
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

2.  Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008-2010 Korea National Health and Nutrition Examination Surveys.

Authors:  Kyung Shik Lee; Ji Su Jang; Dong Ryul Lee; Yang Hyun Kim; Ga Eun Nam; Byoung-Duck Han; Kyung Do Han; Kyung Hwan Cho; Seon Mee Kim; Youn Seon Choi; Do Hoon Kim
Journal:  J Bone Miner Metab       Date:  2013-12-14       Impact factor: 2.626

3.  Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats.

Authors:  Javier Díaz-Castro; Mercedes Ramírez López-Frías; Margarita S Campos; Magdalena López-Frías; María J M Alférez; Teresa Nestares; María L Ojeda; Inmaculada López-Aliaga
Journal:  Eur J Nutr       Date:  2011-06-07       Impact factor: 5.614

4.  1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.

Authors:  Galina Nesterova; May Christine Malicdan; Kaori Yasuda; Toshiyuki Sakaki; Thierry Vilboux; Carla Ciccone; Ronald Horst; Yan Huang; Gretchen Golas; Wendy Introne; Marjan Huizing; David Adams; Cornelius F Boerkoel; Michael T Collins; William A Gahl
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

5.  Regulation of intestinal calcium-binding protein in rats: role of parathyroid hormone.

Authors:  M Thomasset; P Cuisinier-Gleizes; H Mathieu; E E Golub; F Bronner
Journal:  Calcif Tissue Int       Date:  1979-11-26       Impact factor: 4.333

Review 6.  Iron and 25-hydroxyvitamin D in postmenopausal women with osteoporosis.

Authors:  Nasser M Al-Daghri; Sobhy Yakout; Afnan Ghaleb; Syed Danish Hussain; Shaun Sabico
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 7.  Copper, iron, and selenium dietary deficiencies negatively impact skeletal integrity: A review.

Authors:  Denis M Medeiros
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-05

8.  Vitamin D dependence and aboral gradient of in vivo intestinal calcium transport in the rat.

Authors:  M M Petith; J R Wenger; H P Schedl
Journal:  Am J Dig Dis       Date:  1978-10

9.  Classification of idiopathic hypercalciuric patients by isotopic calcium absorption: a comparison with oral calcium tolerance test.

Authors:  R Pacifici; P Filipponi; C Mannarelli; G Vespasiani; M Porena; L Fedeli; V Morucci; L V Avioli
Journal:  Calcif Tissue Int       Date:  1985-09       Impact factor: 4.333

10.  Assessment of the use of LED phototherapy on bone defects grafted with hydroxyapatite on rats with iron-deficiency anemia and nonanemic: a Raman spectroscopy analysis.

Authors:  Isabele Cardoso Vieira de Castro; Cristiane Becher Rosa; João Alves Dos Reis Júnior; Luiz Gaudêncio Passos Moreira; Juliana S Aragão; Artur Felipe dos Santos Barbosa; Landulfo Silveira; Antonio L B Pinheiro
Journal:  Lasers Med Sci       Date:  2014-03-19       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.